Package 67877-532-58

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 67877-532-58
Digits Only 6787753258
Product NDC 67877-532
Product ID 67877-532_1f629ae0-1f1c-4bce-b216-af26d84d24c6
Description

250 mL in 1 BOTTLE (67877-532-58)

Marketing

Marketing Status
Marketed Since 2020-01-01
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Oxcarbazepine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1f629ae0-1f1c-4bce-b216-af26d84d24c6", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0367877532585"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["3f36f519-c30c-4929-afa0-9844dc531e3f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BOTTLE (67877-532-58)", "package_ndc": "67877-532-58", "marketing_start_date": "20200101"}], "brand_name": "Oxcarbazepine", "product_id": "67877-532_1f629ae0-1f1c-4bce-b216-af26d84d24c6", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-532", "generic_name": "Oxcarbazepine", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "60 mg/mL"}], "application_number": "ANDA213183", "marketing_category": "ANDA", "marketing_start_date": "20200101", "listing_expiration_date": "20261231"}